Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Hypoxia Markers and Their Importance

Pediatric Cancer

Cancer Diagnosis

Cancer History

Why are Cancer Cell Lines Useful?

Cancer Symptoms

Insight into Cancer Vaccines

What is Cancer?

The Cancer Cell Surface Proteome as a Therapeutic Target

Cancer Prevention: Lowering your Risk

Transforming Cancer Care through Genomic Testing

See more featured articles »

Cancer Pain

What is Merkel Cell Carcinoma?

Cancer Screening Considerations: Balancing the Benefits and Risks

The Effects of Cancer on Family Life

Cancer Classification

Microfluidic cancer treatment screen combined with flow cytometry

Investigating the Molecular Mechanisms of Cancer

Is Cancer a Metabolic Disorder?

What Role do Biobanks Play in Cancer Research?

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Effects of Social and Economic Deprivation on Cancer Mortality

Caring for a Loved One with Cancer

CDK9 and Cancer

What Causes Cancer?

Living with Cancer Pain

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Insights into Oncofertility

Assay for Monitoring and Treating Malignant Brain Tumors

The Biochemistry of Breast Cancer Screening

Acidosis and Tumor Progression

British Pioneers in Cancer Biology

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

What is Immunochemotherapy?

What is Tumorigenesis?

Cancer Research

What is the Tumor Microenvironment?

Cancer Pain Management

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Secondary Lung Cancer

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Targeted Cancer Therapies

Metastatic Migration in Cancer may be Influenced by Metabolism

Using Biomarkers to Detect Cancer

Myc Mutations and Cancer

Exploiting Enzymes in Cancer Diagnosis and Therapy

Cancer Glossary

Overview of Cell Viability and Cytotoxicity

Hot vs Cold: the differences between tumor types

Cutaneous Manifestations of Internal Malignancy

Cancer Management

Secondary Brain Cancer

Cancer Pathophysiology

TARDIS: The Improved Method of Detecting Breast Cancer

What is Cancer of Unknown Primary?

Cancer Prognosis

Extracellular Vesicles as Floating Cancer Biomarkers

Cancer Epidemiology

Latest Cancer News and Research

Single DNA injection provides long-lasting weight loss in mouse study

Scientists at The Wistar Institute have shown that a single injection of a small, circular piece of genetic instructions can produce weight loss and blood glucose control in murine models that lasts up to 10 times as long as incretin-mimicking drugs like Ozempic and Wegovy.

26 Jun 2026

Multi-decade study tracks subsequent cancer risks in survivors

As people continue to live longer and the survival rate of cancer diagnoses increases, researchers from VCU Massey Comprehensive Cancer Center led a multi-decade analysis studying the rates of subsequent primary cancers (SPCs), which are new cancers unrelated to the original diagnosis.

26 Jun 2026

New screening approach identifies proteins that control human gene expression

Researchers at University of California San Diego have developed a large-scale screening approach that identifies proteins controlling a fundamental step in gene expression known as alternative polyadenylation (APA).

26 Jun 2026

Case report details rare basal cell carcinoma on patient's finger

Basal cell carcinoma is the most prevalent form of skin cancer, typically developing on sun-exposed areas like the face and neck.

26 Jun 2026

Engineered CAR T cells successfully target bladder cancer in mice

Researchers at Weill Cornell Medicine, Cedars-Sinai Medical Center, and Roswell Park Comprehensive Cancer Center have developed genetically engineered CAR T cells that specifically target and kill bladder cancer cells.

26 Jun 2026

Artificial intelligence improves diagnostic accuracy in clinical breast pathology

Artificial intelligence (AI) is increasingly reshaping diagnostic pathology, with breast pathology representing one of the most advanced and clinically impactful areas of adoption.

26 Jun 2026

Biognosys showcases next-gen multiomics innovations at ASMS 2026

The Biognosys Group, a leader in mass spectrometry-based multiomics, announces advancements across its integrated multiomics portfolio, highlighting next-generation software, sample preparation, enrichment, and separation technologies for proteomics and metabolomics.

From Biognosys 26 Jun 2026

AI and multiomics reveal how gut bacteria trigger colon cancer

Over the past two decades, high‑throughput sequencing has dramatically expanded our understanding of the gut microbiome's composition.

26 Jun 2026

Study uncovers self-propelled actin filaments that shape living cells

Every time a white blood cell engulfs a bacterium, a neuron extends a projection to connect with a neighboring cell, or when a cancer cell forcefully squeezes through tissue to spread, the cell must change its shape to accommodate the movement.

26 Jun 2026

Semaglutide approval drove a surge in GLP-1 poison center exposures

Following semaglutide's approval, poison center reports of GLP-1 RA exposures doubled, revealing critical trends in patient safety and healthcare utilization.

26 Jun 2026

Could your birth characteristics influence colorectal cancer risk?

A California study links birth and parental factors to early-onset colorectal cancer risk, highlighting male sex and Hispanic ethnicity as key contributors.

26 Jun 2026

Gut microbes emerge as potential players in estrogen-driven cancers

A new review maps how the endocrine-microbiome axis expands the estrobolome concept, showing that gut microbes may alter estrogen recycling, produce hormone-like metabolites, and shape inflammation and tissue environments in hormone-driven cancers. Human evidence remains mostly associative, so the authors call for causal models, longitudinal multi-omics, multi-kingdom profiling, and sex-stratified studies before microbiome-guided cancer strategies enter routine care.

25 Jun 2026

Lipid nanoparticles enhance immune response against lung cancer

Researchers at the University of Arizona R. Ken Coit College of Pharmacy have developed a new strategy that helps the immune system recognize and attack lung cancer tumors more effectively.

25 Jun 2026

Common drug shows promise in preventing post-surgical liver failure

A multi-center study, co-led by researchers at Mayo Clinic and Michigan State University, found that patients who received tranexamic acid during liver surgery were three times less likely to develop post-hepatectomy liver failure than patients who received a placebo.

25 Jun 2026

Iron overload gradually increases neurons' vulnerability to neurodegeneration

Neurodegenerative diseases affect tens of millions of people worldwide. Among these, Alzheimer's and Parkinson's diseases are the most common; in the United States alone, the Alzheimer's Disease Association and Parkinson's Foundation report roughly 7 million people with Alzheimer's and another million with Parkinson's.

25 Jun 2026

Opposing protein pathways control skin regeneration and disease development

Two proteins with opposing functions orchestrate the development and maintenance of healthy skin, Stanford Medicine researchers have found.

25 Jun 2026

Scientists find a universal gut microbiome pattern linked to colorectal cancer

Researchers analyzed 6,779 stool microbiome profiles and 906 tissue samples to identify a colorectal cancer microbial signature that remained consistent across age groups, populations, and sequencing methods. The signature aligned with tumor-resident microbes, showed weaker detection for adenomas, and was inversely associated with dietary fiber intake.

25 Jun 2026